drugset / Trial / NCT01777581

Milnacipran for Lumbosacral Radicular Pain

NCT01777581 ↗

Phase 4 Completed 13 enrolled Duke University Forest Laboratories · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study investigates whether milnacipran reduces radicular pain ("sciatica") in patients with lumbosacral disc disease.

Timeline

Start
2010-03
Primary completion
2011-10
Completion
2011-10

Outcome

Met primary endpoint

paper Milnacipran treatment yielded statistically significant reduction in radicular pain (VAS-Rad, P = .01) PMID 25664215 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified 100 mg —
Subject Milnacipran Other / unclassified 200 mg —

Indications